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Chairman: Associate Professor Rasedee Abdullah, Ph.D 
Faculty: Veterinary Medicine and Animal Science 
Nephrotic syndrome (NS) is a renal disease featured mainly by proteinuria, 
hypoalbuminemia, oedema, and ascites. The etiologies could be diverse while the signs 
and symptoms are detected only at late stages ofthe disease. This study was conducted 
to assess the response of serum and urine biochemical indicators of renal failure and the 
compensatory mechanisrnls that may be involved in maintaining optimum renal function 
following repeated exposure to mercury chloride (HgCI2). A total of forty-five 
Sprague-Dawley rats aged between eight to ten weeks were injected intravenously 
through tail vein with 0.5 mg ofHgCli kg body weight every alternate days for ten days. 
The same number of rats were injected with 1 ml of normal saline/ kg body weight and 
Xl1 
served as controls. Five rats from each group were killed every four days commencing 
from the fourth day of the last injection. 
There were significant changes observed in the concentration of blood urea 
nitrogen (BUN), serum creatinine, serum total protein, serum albumin, urine total 
protein, and urine albumin during the 42-day experimental period. The concentration 
of BUN begun to increase significantly (P<0.05) by day 22, but returned to normal 
values after the initial increase on day 30 .  While serum creatinine concentration 
fluctuated with two peak values on days 34 and 42. Loss of albumin from plasma was 
observed to be intermittent and urine total protein showed a late increase on day 34. 
Urine albumin showed a significant earlier increase (p<O.05) on day 18, but decreased 
toward control values for the next 8 days before increasing back to a peak value on day 
42. 
The deposition of mercury (Hg) following chronic exposure was high in the 
kidneys and the liver. The concentration of renal Hg was at peak values from day 14 to 
day 22 and gradually decreased thereafter. The renal tubular damage was observed to 
begin on day 1 8  and increased in intensity 26 days into the experiment reaching peak on 
day 42. There was also epithelisation of renal tubular epithelium. This response was 
greater on day '14 and quickly decreased thereon to disappear completely by day 28. 
The extensive damage of renal tubules which began on day 18 onwards could be due to 
an excessive loading of the metal beyond tissue elemental saturation and to the long 
retention ofHg in the tissues. 
X1ll 
The study suggests Hg accumulated predominantly in the kidneys and produced 
a biphasic response of renal-associated biochemical parameters in which urine albumin 
is the possible early indicator to renal damage. Tubular epithelisation could be one of the 
mechanisms involved in maintaining the optimum renal function. 
XlV 
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Pengerusi: Professor Madya Rasedee Abdullah, Ph.D 
Fakulti: Kedoktoran Veterinar dan Sains Peternakan 
Sindrom nefrosis (NS) ialah satu penyakit renal yang dinyatakan oleh proteinuria, 
hipoalbuminemia, edema, dan asitis. Etiologinya mungkin pelbagai, sambil petanda dan 
simptom pula hanya dapat dikesan pada peringkat lewat penyakit ini. Kajian ini 
dikendalikan untuk menilai gerak balas petunjuk biokimia serum terhadap kegagalan 
renal dan mekanisme pampasan yang terlibat dalam penyenggaraan fungsi renal optimum 
berikutan pendedahan berulang kepada merkuri klorida (HgC12). Empat puluh lima ekor 
tikus Sprague-Dawley berumur lapan hingga sepuluh minggu disuntik secara intravena 
menerusi vena ekor dengan 0.5 mg HgCI/kg berat badan setiap selang satu hari selama 
sepuluh hari. Sejumlah sarna tikus disuntik dengan 1 ml 0.85% natrium klorida 
xv 
(NaCI2)/kg berat badan bertindak sebagai kawalan. Lima ekor tikus daripada setiap 
kumpulan dimatikan setiap empat hari bermula empat hari selepas suntikan terakhir. 
Perubahan tererti (P<O. 05) telah dicerapkan dalam kepekatan nitrogen urea darah 
(BUN), kreatinin serum, protein sepenuh dan albumin serum, protein sepenuh dan 
albumin urin sepanjang tempoh 42 hari ujikaji. Kepekatan BUN mula meningkat secara 
tererti (P<O. 05) pada hari 22 dan kembali kepada normal selepas peningkatan awal, pada 
hari 30. Sambi! itu kepekatan kreatinin serum beralun dengan dua nilai kemuncak pada 
hari 34 dan 42. Kehilangan albumin daripada plasma dicerapkan tidak selanjar dan 
protein sepenuh urin menunjukkan peningkatan lewat pada hari 34.  Albumin urin 
menunjukkan peningkat tererti (P<0.05) lebih awal pada hari 1 8  tetapi menurun semula 
ke arah nilai kawalan selama 8 hari berikutannya sebelum ia meningkat semula kepada 
nilai kemuncak pada hari 42. 
Pengenapan merkuri (Hg) berikutan pendedahan kronik adalah tinggi dalam 
ginj al dan hati. Kepekatan Hg renal berada pada nilai kemuncak daripada hari 14 hingga 
22 dan beransur kurangan sejurus selepas itu. Kerosakan tubul renal dicerap bermula 
pada hari 1 8  dan meningkat keamatannya selepas 26 hari ke dalam tempoh ujikaji dengan 
mencapai kemuncak pada hari 42. Keepiteliuman tubul renal juga berlaku. Gerak balas 
ini lebih tinggi pada hari 14  dan cepat mengurang selepas itu untuk hilang terus pada hari 
28 . Kerosakan teruk tubul renal yang bermula pada hari 1 8  mungkin disebabkan oleh 
pembebanan berlebihan logam ini hingga melebihi ketepuan unsur tisu dan oleh 
penahanan Hg dalam tisu. 
XVi 
Kajian ini menyarankan Hg terkumpul secara keutamaan dalam ginjal dan 
menghasilkan gerak balas dwifasa parameter biokimia berkaitan renal, yang mana 
albumin urin mungkin merupakan petunjuk awal kepada kerosakan ginjal. Keepiteliuman 
tubul mungkin merupakan satu daripada mekanisme yang terlibat dalam menyengarakan 




Mercury-Induced Nephrotic Syndrome: A Correlation Between 
Pathological Changes and Serum Biochemical Parameters 
In recent years, there has been growing concern over the extent of environmental 
contamination with toxic metals due to industrial development. Among the fourteen 
environmental contaminants currently specified under the US Extraction Procedure (EP) 
Toxicity Test, Hg is rather high on the list. 
The concentration of Hg in the environment is, in part, the result of waste 
products from manufacturing processes which utilise Hg or the disposal of products 
containing Hg. On a global basis, it is estimated about 1 0  metric tons mercuric waste 
per year is released into fresh water and about 480 metric tons per year into oceans 
(Von Burg and Greenwood, 1991 ). These mercuric wastes may sediment at the bottom 
of the lakes, rivers, and seas. There, the bacteria and fungi methylate the inorganic Hg 
to organic form and introduces the threat into the food chain (Hansen et aI., 1989). 
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Accumulated Hg in the food chain, with fish and shellfish being the dominant 
reservoir, responsibles for poisoning in some communities, or undergoes 
biotransformation and released into th e atmosphere as elemental Hg. 
The most common forms of Hg exposed to humans and animals can be 
categorised into three classes; metallic Hg, inorganic Hg, and organic Hg (Clarkson, 
1972). Each class ofHg has different pharmacokinetic properties with regard to their 
uptake and absorption, distribution in the body , metabolism, and toxic effects. 
Based on present evidence, Hg is not considered essential for living organisms 
(Underwood, 1977). In fact, Hg is extremely toxic even in relatively small amounts and 
is bioaccumulative. Mercury is known particularly to be a potential nephrotoxic agent 
(Bariety et al., 1971). Methy lmercury is by far recognised as th e most toxic form ofHg 
and it represents great risks of irreversible functional damage to both humans and 
animals. 
The two main routes of Hg entry into the body leading to toxicosis are ingestion 
( the food chain) and inhalation ( atmostphere). Regardless of the chemical form and 
route of entry, following exposure, the kidney h as been recognised to accumulate the 
highest concentration ofHg ( Greenwood et a!., 1990). Th e association ofHg toxicosis 
and neph rotic sy ndrome h as long been established (Mandema et al., 1963). 
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Studies so far have shown that chronic exposure to HgCl2 could lead to an 
induction of biphasic membranous glomerulonephritis in Brown Norway rats ( Sapin et 
al., 1 977; Druet et al., 1 978). A similar immunological process was also observed in 
human. 
The kidneys, although vulnerable, have a very high compensatory ability. It 
could compensate up to 70% loss of functional mass. However, this unique feature has 
contributed to the difficulty of detecting renal insufficiency at very early stages. Both 
biochemical and morphological techniques are still incapable of detecting early damage. 
Thus, this study was undertaken to determine the effects ofHg as an inducer of 
NS with the following objectives: 
a. to determine relevant biochemical parameters that may be used as early 
indicators of renal damage. 
b. to determine the correlation between pathological changes and selected 
serum and urine biochemical parameters. 
c. to determine the Hg concentration in kidney and liver tissues in 
conjunction with the development of nephrosis. 
CHAPTER 2 
LITERA TURE REVIEW 
Nephrotic Syndrome 
Introduction 
Nephrotic syndrome (NS) is a renal disease of varied etiologies characterised 
by hypoalbuminemia, proteinuria, ascites, and oedema (Coggins and Maffiy, 1985). The 
hallmark of this condition is attributed to an increase in the glomerular permeability due 
to the loss of fixed negative charges on the glomerular membrane. This in tum allows 
negatively charged polyanions, particularly albumin, to enter renal tubules and to be 
excreted into urine (Coggins and Maft1y, 1985). 
Massive proteinuria is the most prominent feature ofNS. A nephrotic patient 
can excrete as much as 3. 5 g of protein per day through the urine (Coggins and Maft1y, 
1985; Wilson, 1986a). The loss of protein into the urine directly decreases the plasma 
concentration of albumin and forces the plasma fluid out of blood vessels into tissue 
interstitial spaces and causing ascites and oedema. In addition, the phenomenon of 
elevated plasma renin and aldosterone activity due to hypovolemia, as a result of plasma 
protein loss, causes the kidney to retain more sodium and water (Wilson, 1986a). The 
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retention of sodium, water and other electroly tes further contributes to the increase in 
extracellular fluid accumulation, and this explains the contraindications of removing 
excess fluid which could further aggravate the edematous condition. 
Classification of Renal Lesion in Nephrotic Syndrome 
Glomerulonephritis, either primary or secondary , is a bilateral inflammatory 
disease of the kidney which begins in the glomerulus (Wilson, 1986b). Approximately 
50% of chronic glomerulonephritis (CGN) will eventually give rise to NS (Coggins and 
Maffiy , 1985). Primary glomerulonephritis representing 75% of the incidence (Coggins 
and Maffly ,  1985) and can further be subclassified into four histologic entities, namely ; 
membranous nephropathy ; minimal lesion glomerulonephritis; focal glomerular sclerosis; 
and mesangial proliferative glomerulonephritis (MPGN) (Wilson, 1986b). 
Membranous Nephropathy 
Almost one-third of NS cases originated from lesions of membranous 
nephropathy (Coggins and Maffiy , 1985). In this case, microscopic and ultrastructural 
studies revealed thickened glomerular capillary wall due to deposits of immune 
complexes (Row et aI., 1975; Wilson, 1986b). The involvement of the immune 
mechanism can be demonstrated by immunoflourescence staining to show the presence 
ofIgG and complement deposits (Wilson, 1986b). In the United States, nearly half of 
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the total number of adult patients with idiopathy showed this form ofNS at biopsy 
(Glassock et aI. , 1981). 
The response of membranous nephropathy to corticosteroid and 
immunosuppressive therapy is poor with variable prognosis which either show complete 
remission, improvement but still having proteinuria, persistent nephritis, or slowly 
progressing to chronic renal failure (Row et aI. , 1975; Noel et aI. , 1979). 
Minimal Lesion Glomerulonephritis 
Minimal lesion glomerulonephritis, also known as lipoid nephrosis or foot 
process disease (Wilson, 1986b), represents 15% of the incidence of NS (Cameron et 
al., 1974). This is the only form of NS which does not involve immunopathology 
(Cameron et al., 1974; Wilson, 1986b). The glomeruli may appear normal or nearly 
normal under light microscope but lipid accumulation is seen in the epithelial cells of the 
tubules whilst electron microscope studies revealed fusion of the foot processes (Wilson, 
1986b). The contributing factors associated with this ty pe of lesion are diverse. It 
could be food allergy, foreign agents, or Hodgkin's disease (Moorthy et aI., 1976). This 
ty pe of NS accounted for 80 - 90% of cases affecting children of primary 
glomerulonephritis aged between one to five y ears old (Coggins and Maffiy , 1985). The 
prognosis is very good since the disease responds readily to corticosteroid treatment and 
rarely progress to renal failure (!<ida et aI. , 1977). 
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Focal Glomerular Sclerosis 
The third typical form of glomerulonephritis is focal glomerulosclerosis. A 
sclerotic process which takes place within the glomeruli with ensuing renal insufficiency. 
The pathogenetic mechanism initially involves deeper juxtamedullary nephrons and it 
may or may not be detected at early renal biopsy (Wilson, 1986b). It is usually 
associated with tubular defects which lead to glycosuria, aminoaciduria, renal tubular 
acidosis, and phosphaturia. It has also been reported as a complication of AIDS (Rao 
et aI., 1984). 
Mesangial Proliferative Glomerulonephritis 
Mesangial proliferative glomerulonephritis (MPGN) involves the proliferation 
of mesangial cells (Wilson, 1986b). Immunoflourescent studies showed deposition of 
IgA or IgM in the mesangium. The thickened glomerular basement membrane gave rise 
a lobular or "wire-loop" appearance under light microscope. This type of lesion is 
closely associated with lupus nephritis. A common manifestation of MPGN is 
hypertension and microscopic haematuria. Normally the prognosis is poor and may 
slowly progress to chronic renal failure (Wilson, 1986b). 
Etiologies of Nephrotic Syndrome 
The causes of NS could be diverse, encompassing infectious organisms of the 
urinary tract, secondary to certain systemic diseases, or toxic agents. In most cases, the 
